Publications by authors named "H Enzmann"

Claim this Profile
H
How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers.
Silvia Stacchiotti, Pan Pantziarka, Hugh Leonard, Caroline Voltz, Laura Abatedaga, Harald Enzmann

Cancer Treat Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop.
Madeline Pe, Caroline Voltz-Girolt, Jill Bell, Vishal Bhatnagar, Jan Bogaerts, Harald Enzmann

Lancet Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The EMA Assessment of Asciminib for the Treatment of Adult Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Who Were Previously Treated With at Least Two Tyrosine Kinase Inhibitors.
C Mircea S Tesileanu, Sotirios Michaleas, Rocio Gonzalo Ruiz, Segundo Mariz, Babs O Fabriek, Harald Enzmann

Oncologist· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European Medicines Agency review of sacituzumab govitecan for the treatment of triple-negative breast cancer.
S Michaleas, A Moreno Oliver, J Mueller-Berghaus, S B Sarac, M E van der Elst, H Enzmann

ESMO Open· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attention for sex in COVID-19 trials: a review of regulatory dossiers.
Sieta T de Vries, Viktoriia Starokozhko, Ingrid M M Schellens, Leonoor Wijnans, Harald Enzmann

BMJ Glob Health· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis